Spontaneous Recovery of Neuromuscular Function after Atracurium in Pediatric Patients

Spontaneous recovery of neuromuscular function after a bolus dose of 0.40 mg/kg atracurium was assessed in 60 newborn to adolescent patients during balanced anesthesia. Each patient was allowed to recover spontaneously until complete recovery of the single twitch (T1) response and the train-of-four ratio measured from the hypothenar muscle evoked compound EMG. The recovery times of T1 from the onset of relaxation to 10% recovery and to 100% recovery were significantly longer in patients under 10 kg of body weight than in the heavier patients (25 and 56 min vs 19 and 45 min, respectively, P < 0.01). The rate of recovery, calculated as the recovery index (time between 25% recovery and 75% recovery of T1), was significantly longer in patients under 2 months of age than in older infants or children and adolescents. Atracurium remains, nevertheless, a relaxant of intermediate duration of action even in small infants.

[1]  L. M. Liu,et al.  Neuromuscular effects of atracurium in infants and children. , 1985, Anesthesiology.

[2]  R. Matteo,et al.  Distribution, Elimination, and Action of d‐Tubocurarine in Neonates, Infants, Children, and Adults , 1984, Anesthesia and analgesia.

[3]  C. Coté,et al.  Safety and efficacy of atracurium in adolescents and children anesthetized with halothane. , 1983, Anesthesiology.

[4]  R. Miller,et al.  Neuromuscular Effects of Vecuronium (ORG NC45) in Infants and Children during N2O, Halothane Anesthesia , 1983, Anesthesiology.

[5]  M. Mehta,et al.  Safety and Efficacy of Atracurium (BW33A) in Surgical Patients Receiving Balanced or Isoflurane Anesthesia , 1983, Anesthesiology.

[6]  D. R. Cook,et al.  Clinical pharmacology of atracurium in paediatric patients. , 1983, British journal of anaesthesia.

[7]  H. H. Ali,et al.  Clinical Pharmacology of Atracurium Besylate (BW 33A): A New Non‐depolarizing Muscle Relaxant , 1982, Anesthesia and analgesia.

[8]  P. Lilleaasen,et al.  Dose-response relation for atracurium, ORG NC 45 and pancuronium. , 1982, British journal of anaesthesia.

[9]  E. Yodlowski,et al.  Assessment of Neuromuscular Function in Infants , 1981, Anesthesiology.

[10]  R. Hughes,et al.  The pharmacology of atracurium: a new competitive neuromuscular blocking agent. , 1981, British journal of anaesthesia.

[11]  N. Goudsouzian Maturation of neuromuscular transmission in the infant. , 1980, British journal of anaesthesia.

[12]  G. Long,et al.  Neuromuscular Blockade by d‐Tubocurarine in Children , 1967, Anesthesiology.